Emergence of Vanrija humicola as a pathogen of urinary tract infections in Korea
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Vanrija humicola, a yeast belonging to Trichosporonaceae, is rarely pathogenic. All cases of isolation of V. humicola were retrospectively reviewed from 2021 to 2023. A total of four V. humicola were isolated from urine samples. Organisms cultured for 5 days at 25°C produced yellow, dry and cerebriform colonies, and were successfully identified as V. humicola using Bruker Biotyper MALDI-TOF. Two recent isolates were resistant to fluconazole, echinocandins, and flucytosine. In all 4 cases, V. humicola was sporadically isolated more than 14 days after admission. One case was presumed to be colonized. Of the other three cases that developed a urinary tract infection (UTI), only one with pancytopenia was treated for UTI by V. humicola with caspofungin, but expired 4 days later. V. humicola has emerged as a drug-resistant fungal pathogen of hospital-acquired UTI. Species identification and antifungal susceptibility testing of this organism are required for critical patients.
Abstract
Vanrija humicola, a yeast belonging to Trichosporonaceae, is rarely pathogenic. All cases of isolation of V. humicola were retrospectively reviewed from 2021 to 2023. A total of four V. humicola were isolated from urine samples. Organisms cultured for 5 days at 25°C produced yellow, dry and cerebriform colonies, and were successfully identified as V. humicola using Bruker Biotyper MALDI-TOF. Two recent isolates were resistant to fluconazole, echinocandins, and flucytosine. In all 4 cases, V. humicola was sporadically isolated more than 14 days after admission. One case was presumed to be colonized. Of the other three cases that developed a urinary tract infection (UTI), only one with pancytopenia was treated for UTI by V. humicola with caspofungin, but expired 4 days later. V. humicola has emerged as a drug-resistant fungal pathogen of hospital-acquired UTI. Species identification and antifungal susceptibility testing of this organism are required for critical patients.
참고문헌 (14)
- Moore RT, "Taxonomic proposals for the classification of marine yeasts and other yeast-like fungi including the smuts", Botanica Marina, 23, pp.361~373 (1980)
- Alvarez Gasca MA, "Fungal agents isolated from cancer patients", Rev Latinoam Microbiol, 40, pp.15~24 (1998)
- Morales-Lopez SE, "Infections due to rare Cryptococcus species. A literature review", J Fungi, 7, pp.279~ (2021)
- Liu XZ, "Towards an integrated phylogenetic classification of the Tremellomycetes", Stud Mycol, 81, pp.85~147 (2015)
- Schoch CL, "NCBI taxonomy : a comprehensive update on curation, resources and tools", Database(Oxford), 2020, pp.baaa062~ (2020)
- Garcia-Martos P, "Susceptibility to antifungal agents of Cryptococcus species of clinical interest", Med Clin(Barc), 119, pp.211~213 (2002)
- Nitzulescu V, "Cryptococcus species isolated from an ocular lesion", Arch Roum Pathol Exp Microbiol, 34, pp.363~365 (1975)
- Ramli SR, "Cryptococcus humicolus meningitis : first case report in Malaysia", Southeast Asian J Trop Med Public Health, 43, pp.1212~1217 (2012)
- Rogowska-Szadkowska D, "Candida humicola infection of the central nervous system in an HIV-infected patient : a case report", Przegl Epidemiol, 51, pp.465~469 (1997)
- Shinde SM, "Systemic humicolus cryptococcosis", Indian Pediatr, 41, pp.1162~1164 (2004)
- Sugita T, "Two new yeasts, Trichosporon debeurmannianum sp. nov. and Trichosporon dermatis sp. nov., transferred from the Cryptococcus humicola complex", Int J Syst Evol Microbiol, 51, pp.1221~1228 (2001)
- Reddy AK, "Is blood agar an alternative to sabouraud dextrose agar for the isolation of fungi in patients with mycotic keratitis", Int Ophthalmol, 33, pp.251~254 (2013)
- Fisher JF, "Candida urinary tract infections--treatment", Clin Infect Dis, 52(Suppl 6), pp.S457~66 (2011)
- Bernal-Martinez L, "Susceptibility profile of clinical isolates of non-Cryptococcus neoformans", non-Cryptococcus gattii Cryptococcus species and literature review, 2010, pp.48, 90~96